AUDUBON, Pa. (July 29, 2011) – Globus Medical, Inc., the largest privately held spinal implant manufacturer in the world, today announced it has appointed Ann D. Rhoads to serve as a member of the Company’s Board.
“We are very pleased to have Ms. Rhoads join our board. She brings a wealth of knowledge and experience in finance, strategy, and business management,” said David Paul, Chairman and CEO of Globus Medical. “Ann’s expertise and background will be invaluable as a member of our Audit Committee, and help Globus continue its success as we grow towards our goal of becoming the preeminent spine company.”
Ms. Rhoads currently serves as Executive Vice President, Chief Financial Officer, Treasurer and Secretary for Zogenix, Inc (NASDAQ:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain. Previously, Ms. Rhoads was with Premier, Inc., a healthcare service company, as Senior Vice President and Chief Financial Officer. At Premier her responsibilities included all areas of financial management, strategic planning, business development, information technology, ethics, and compliance. Prior to joining Premier, Ms. Rhoads held various positions at Sprout Group, a venture capital affiliate of Donaldson, Lufkin & Jenrette, Bain & Company, and Merrill Lynch Capital Partners.
Ms. Rhoads received a B.S. in Business Administration from the University of Arkansas and an M.B.A. from the Harvard Business School. Ms. Rhoads is a member of the board of directors of Novellus Systems, Inc. (NASDAQ:NVLS).